Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences [2]

Fertility and Sterility

Volumn 77, Issue 5, 2002, Pages 1081-1082

  Kadowaki, Masahiro ^a   Murakami, Takashi ^a   Morita, Junko ^a   Terada, Yukihiro ^a   Yaegashi, Nobuo ^a   Okamura, Kunihiro ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; GONADORELIN DERIVATIVE; LEUPRORELIN; NAFARELIN;

ADULT; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DYSMENORRHEA; FEMALE; FEMALE INFERTILITY; HORMONAL THERAPY; HUMAN; HYPERMENORRHEA; INTERMETHOD COMPARISON; LETTER; MAJOR CLINICAL STUDY; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS PAIN SYNDROME; PREDICTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; TUMOR VASCULARIZATION; TUMOR VOLUME; UTERUS BLEEDING; UTERUS MYOMA;

EID: 0036260789     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03062-5     Document Type: Article

References (10)

1. Uterine leiomyomata: Etiology, symptomatology, and management
2. Treatment of leiomyomata uteri with leuprolide acetate depot: A double-blind, placebo-controlled, multicenter study
3. Absence of a dose-response effect of leuprolide acetate on leiomyomata uteri size
4. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin releasing-hormone agonist
5. Monitoring therapy with a gonadotropin-releasing hormone analog: Utility of MR imaging
6. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: Assessment by magnetic resonance imaging
7. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: Correlation between T2-weighted images and effect of GnRH analogue
8. Hyperintense uterine leiomyoma at T2-weighted MR imaging: Differentiation with dynamic enhanced MR imaging and clinical implications
9. MR detection of degenerating uterine leiomyomas
10. MR imaging in the evaluation of benign uterine masses: Value of gadopentetate dimeglumine-enhanced T1-weighted images